Thomas Cherrier
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 8
- HIV Research and Treatment 8
-
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Olivier Rohr (10 shared papers)Christian Schwartz (9 shared papers)Lætitia Redel (6 shared papers)Carine Van Lint (4 shared papers)Valentin Le Douce (8 shared papers)Dominique Aunis (6 shared papers)Aurore Hick (1 shared paper)Ziad Al Tanoury (1 shared paper)
- Journals
- Cell Death and Disease (2 papers)Nature Protocols (1 paper)Virology Journal (1 paper)Journal of Leukocyte Biology (1 paper)Oncogene (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Thomas Cherrier
16 papers receiving 544 citations
Peers
Comparison fields: 5 of 70
- Virology 160
- Infectious Diseases 94
- Molecular Biology 329
- Immunology 82
- Genetics 33
Countries citing papers authored by Thomas Cherrier
This map shows the geographic impact of Thomas Cherrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cherrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cherrier more than expected).
Fields of papers citing papers by Thomas Cherrier
This network shows the impact of papers produced by Thomas Cherrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cherrier. The network helps show where Thomas Cherrier may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Cherrier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 202 | |
| 2 | 2009 | 97 | |
| 3 | 2011 | 65 | |
| 4 | 2009 | 55 | |
| 5 | 2011 | 25 | |
| 6 | 2013 | 23 | |
| 7 | 2020 | 23 | |
| 8 | 2011 | 16 | |
| 9 | 2019 | 10 | |
| 10 | 2010 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2010 | 6 | |
| 13 | 2010 | 6 | |
| 14 | 2014 | 3 | |
| 15 | 2010 | 2 | |
| 16 | 2025 | 1 |
About Thomas Cherrier
Thomas Cherrier is a scholar working on Virology, Molecular Biology, Immunology, Hepatology and Infectious Diseases, having authored 16 papers that have together received 549 indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Phagocytosis and Immune Regulation (3 papers), Hepatitis C virus research (3 papers), RNA modifications and cancer (3 papers), Immune cells in cancer (3 papers), Immune Cell Function and Interaction (3 papers), Ubiquitin and proteasome pathways (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Virology (160 citations), Infectious Diseases (94 citations), Molecular Biology (329 citations), Immunology (82 citations) and Genetics (33 citations). Thomas Cherrier has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Olivier Rohr, Christian Schwartz, Lætitia Redel, Carine Van Lint, Valentin Le Douce, Dominique Aunis, Aurore Hick, Ziad Al Tanoury, Bénédicte Gobert and Suvi Aivio. Their work appears in journals such as Cell Death and Disease, Nature Protocols, Virology Journal, Journal of Leukocyte Biology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.